OraSure Technologies OraSure Technologies Q1 Revenues Jump 85 Percent The firm announced that it has submitted a COVID-19 antigen test for Emergency Use Authorization review by the US Food and Drug Administration. OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices. OraSure Saliva Collection Device Gets Canada Authorization for COVID-19 Testing The device also has Emergency Use Authorization from the US Food and Drug Administration and has CE marking for in vitro diagnostic use. DNA Genotek Gets FDA Emergency Use Authorization for Saliva Collection Devices The saliva collection devices are designed for use with third-party SARS-CoV-2 tests or home/self-collection kits and are not intended for sale to patients. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs DNA Genotek's devices are used with SARS-CoV-2 tests from Clinical Reference Laboratory and P23 Labs, while Clinical Enterprises' kit is offered by Eurofins. Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 21, 2020 Evercore ISI Initiates Coverage of OraSure Technologies With Outperform Rating Aug 5, 2020 OraSure Technologies Q2 Revenues Drop 25 Percent, Miss Analysts Estimates Jun 19, 2020 New Products Posted to GenomeWeb: LGC SeraCare, Novacyt, OraSure DNA Genotek Jun 8, 2020 FDA Grants Emergency Use Authorizations for Phosphorus Diagnostics, Genetron Coronavirus Tests Jun 3, 2020 OraSure Technologies Prices $82.5M Stock Offering May 22, 2020 P23 Labs Receives FDA Emergency Use Authorization for SARS-CoV-2 Test May 6, 2020 OraSure Technologies Q1 Revenues Rise 5 Percent Feb 19, 2020 OraSure Technologies Q4 Revenues Down 1 Percent Jan 22, 2020 M&A Deals in MDx/Omics Research Tools Space Up 13 Percent in 2019 Premium Jan 22, 2020 OraSure's DNA Genotek Gets FDA Clearance for Sample Collection Kits Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Dec 17, 2019 Prescient Metabiomics, CoreBiome Developing Microbial Assay for Colon Cancer Screening Nov 7, 2019 OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy Premium Nov 6, 2019 OraSure Q3 Revenues Fall 22 Percent; Firm Announces $12M All-Cash Buy of Diversigen Aug 23, 2019 In Brief This Week: Neogen, Bio-Rad, Orasure Jan 4, 2019 OraSure Technologies Acquires CoreBiome, Novosanis Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.